Our annual report for Research Ethics Committees (RECs) is now available.
The annual report reflects on the last year and the work done to ensure we make the most use of our members’ valuable time, while continuing to deliver a high-quality service.
Between 2021 and 2022, we:
- reviewed 2674 applications requiring full REC review with a median timeframe of 31 days, with 96% reviewed in less than 60 days
- reviewed 751 Proportionate Review applications with a median timeframe of 18 days
- we started to deliver new, in person REC Development Days across England
- started our #StepForward recruitment campaign to attract new potential REC members
- provided training on and fully rolled out our combined review process for Clinical Trials of Investigational Medicinal Products (CTIMPs), which provides the REC opinion and MHRA authorisation delivered as a single UK decision.
Looking forward to 2023, our RECs want to continue doing great work. In 2023, we aim to recruit new members and increase diversity so that we can provide a service that is more reflective of the population it protects.
